Fate Therapeutics, Inc. (FATE)

Fate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.25	36.06	41.87	61.33	133.58	167.35
Short-Term Investments	181.58	243.01	273.31	374.89	482.33	315.57
Cash & Short-Term Investments	222.83	279.07	315.18	436.23	615.91	482.92
Cash Growth	-26.91%	-11.46%	-27.75%	-29.17%	27.54%	118.09%
Accounts Receivable	1.4	3.54	1.83	38.48	8.68	5.52
Other Current Assets	16.4	19.53	29.72	42.59	24.05	21.12
Total Current Assets	230.4	291.91	331.54	502.07	633.41	494.32
Net Property, Plant & Equipment	104.91	110.89	158.51	176.09	162.25	99.39
Long-Term Investments	26.1	27.66	0.98	4.94	100.66	-
Other Long-Term Assets	-	0.01	0.01	7.23	9.9	13.52
Total Assets	371.63	440.69	506.22	705.56	921.46	622.46
Accounts Payable	4.04	9.37	4.72	8.27	8.61	6.28
Accrued Expenses	18.18	21.35	27.51	53.93	42.41	15.56
Current Portion of Leases	5.66	7.42	6.18	5.63	5.58	3.36
Unearned Revenue	-	0.39	0.69	42.23	21.48	21.14
Other Current Liabilities	0.8	-	-	4	3.2	39.22
Total Current Liabilities	28.67	38.52	39.09	114.05	81.28	85.56
Long-Term Leases	75.68	77.85	97.36	103.71	109.24	93.94
Other Long-Term Liabilities	5.92	5.6	1.35	3.86	52.09	58.51
Total Long-Term Liabilities	81.6	83.45	98.71	107.57	161.33	152.45
Total Liabilities	110.27	121.97	137.8	221.62	242.62	238.01
Preferred Stock	0	0	0	0	0	0
Common Stock	0.12	0.11	0.1	0.1	0.1	0.09
Additional Paid-in Capital	1,731	1,716	1,580	1,536	1,449	941.22
Accumulated Other Comprehensive Income	0.06	0.27	0.02	-1.85	-0.76	0.07
Retained Earnings	-1,470	-1,398	-1,212	-1,051	-769.08	-556.93
Shareholders' Equity	261.36	318.73	368.42	483.94	678.84	384.45
Total Liabilities & Equity	371.63	440.69	506.22	705.56	921.46	622.46
Total Debt	81.33	85.27	103.54	109.34	114.82	97.3
Net Cash (Debt)	141.5	193.8	211.64	326.89	501.09	385.62
Net Cash Growth	-26.99%	-8.43%	-35.26%	-34.77%	29.95%	98.26%
Net Cash Per Share	1.22	1.75	2.12	3.38	5.29	4.68
Book Value	261.36	318.73	368.42	483.94	678.84	384.45
Book Value Per Share	2.25	2.88	3.69	5.00	7.16	4.67
Tangible Book Value	261.36	318.73	368.42	483.94	678.84	384.45
Tangible Book Value Per Share	2.25	2.88	3.69	5.00	7.16	4.67

Updated Aug 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q